Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus Protection

New tools are needed to support pre-exposure prophylaxis (PrEP) adherence for human immunodeficiency virus (HIV) prevention, including those that enable real-time feedback. In a large, completed PrEP trial, adequate urine tenofovir levels measured using a novel immunoassay predicted HIV protection a...

Descripción completa

Detalles Bibliográficos
Autores principales: Stalter, Randy M, Baeten, Jared M, Donnell, Deborah, Spinelli, Matthew A, Glidden, David V, Rodrigues, Warren C, Wang, Guohong, Vincent, Michael, Mugo, Nelly, Mujugira, Andrew, Marzinke, Mark, Hendrix, Craig, Gandhi, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850546/
https://www.ncbi.nlm.nih.gov/pubmed/33527128
http://dx.doi.org/10.1093/cid/ciaa785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850546/
https://www.ncbi.nlm.nih.gov/pubmed/33527128
http://dx.doi.org/10.1093/cid/ciaa785

Ejemplares similares